A New Class of Chemically Modified Small RNA Inhibitors against Fusobacterium nucleatum

一类新型化学修饰小 RNA 抑制剂,抗具核梭杆菌

基本信息

  • 批准号:
    10534754
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-02-01 至 2023-04-30
  • 项目状态:
    已结题

项目摘要

Oral microbiome represents an exciting frontier in medicine, and early successes in the field have demonstrated the dynamic interactions among individual microbial species and highlighted the crosstalk between oral microbiota and their hosts at the mucosal interface. While the oral microbiome field has made impressive strides toward these goals, much of our knowledge is typically inferred from correlation studies between bacterial compositions and disease progression. However, there is an immediate need for targeted modulators to prove a causal relationship by selectively eliminating individual species in a multispecies community in a manner analogous to genetic tools that identify links between genotype and phenotype via targeted knockouts. The present R03 application will build on a recent fundamental study by our collaborators, which uncovered crosstalk between Fusobacterium nucleatum (Fn) and transfer RNA-derived small RNAs (tsRNAs) derived from human saliva and oral epithelial cells. Fn is a key oral commensal and opportunistic periodontal pathogen, and has garnered much attention due to its implications in periodontal diseases, preterm birth, and colon cancer. However, no tool exists that can selectively eliminate Fn to understand its role in complex diseases. In parallel, tsRNA represents a new class of small RNAs that can modulate gene expression in prokaryotes and eukaryotes, and recent work has demonstrated that host cells may employ certain tsRNAs to target Fn. Specifically, immortalized human oral epithelial cells can release tsRNA-000794 and tsRNA-020498 in response to Fn infection. Intriguingly, synthetic mimics of tsRNA-000794 and tsRNA-020498, but not scrambled RNA sequences, can kill Fn in planktonic culture, but not Porphyromonas ginigivalis, a gram-negative periodontal pathogen, or Streptococcus mitis, a health-associated gram-positive oral bacterium. However, micromolar concentrations are needed to achieve inhibition against different Fn strains, which poses a challenge for potential applications. To address this limitation, the PI has leveraged his background in RNA chemistry and delivery to chemically modify terminal nucleotides at the 5’ and 3’ ends of the two tsRNAs (MOD-tsRNAs). Impressively, this invention resulted in ~1000-fold reductions in the concentrations of MOD-tsRNA-000794 and MOD-tsRNA-020498 to achieve equivalent potency and specificity against Fn compared to natural counterparts. Motivated by the preliminary data, we will perform two independent and complementary aims towards this new class of MOD-tsRNA inhibitors. Specifically, we will demonstrate the efficacy and specificity of MOD-tsRNAs against Fn using relevant in vitro biofilm and multispecies models (Aim 1). In parallel, we will identify the targets of MOD-tsRNAs in Fn (Aim 2). While this application focuses on two specific tsRNAs and one oral microbe, the conceptual framework will pave the way for a new class of host-derived small RNA inhibitors towards genetic tool and therapeutic development, considering the already successful trajectories of other nucleic acid-based technologies.
口腔微生物组代表了医学中令人兴奋的前沿,该领域的早期成功已经证明 单个微生物物种之间的动态相互作用,并强调了口腔之间的串扰 微生物群和它们的宿主在粘膜界面。虽然口腔微生物组领域已经取得了令人印象深刻的进步, 为了实现这些目标,我们的大部分知识通常是从细菌之间的相关性研究中推断出来的。 组合物和疾病进展。然而,目前迫切需要靶向调节剂来证明, 通过选择性地消除多物种群落中的个别物种的因果关系, 类似于通过靶向敲除鉴定基因型和表型之间联系的遗传工具。的 目前的R 03应用程序将建立在我们的合作者最近的基础研究上,该研究发现了串扰 具核梭杆菌(Fn)与来自人的转移RNA衍生的小RNA(tsRNA)之间的相互作用 唾液和口腔上皮细胞。Fn是一种重要的口腔黏膜和牙周条件致病菌, 由于其在牙周病、早产和结肠癌中的意义而获得了很多关注。但是,在这方面, 不存在可以选择性地消除Fn以了解其在复杂疾病中的作用的工具。与此同时,TSRNA 代表了一类新的小RNA,可以调节原核生物和真核生物中的基因表达, 最近的工作已经证明宿主细胞可以利用某些tsRNA靶向Fn。具体来说, 人口腔上皮细胞可响应于Fn感染而释放tsRNA-000794和tsRNA-020498。有趣的是, tsRNA-000794和tsRNA-020498的合成模拟物,但不是乱序RNA序列,可以杀死 牙周培养,但不是牙龈卟啉单胞菌,一种革兰氏阴性牙周病原体,或链球菌 一种与健康相关的革兰氏阳性口腔细菌。然而,需要微摩尔浓度, 实现对不同Fn菌株的抑制,这对潜在应用提出了挑战。为了解决这个 由于局限性,PI利用他在RNA化学和递送方面的背景, 在两个tsRNA的5'和3'末端的核苷酸(MOD-tsRNA)。令人印象深刻的是,这项发明导致了 MOD-tsRNA-000794和MOD-tsRNA-020498的浓度降低约1000倍,以实现 与天然对应物相比,对Fn具有等效的效力和特异性。由于初步的 数据,我们将对这类新的MOD-tsRNA抑制剂进行两个独立和互补的目标。 具体地,我们将使用相关的体外实验来证明MOD-tsRNA针对Fn的功效和特异性。 生物膜和多物种模型(目的1)。同时,我们将鉴定Fn中MOD-tsRNA的靶标(目的2)。 虽然这个应用程序的重点是两个特定的tsRNA和一个口腔微生物,概念框架将铺平 一类新的宿主衍生的小RNA抑制剂朝向遗传工具和治疗开发的方向, 考虑到其他基于核酸的技术已经成功的轨迹。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jiahe Li其他文献

Jiahe Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jiahe Li', 18)}}的其他基金

Enzymatic and genetic strategies for targeting disease-associated microbial metabolites
针对疾病相关微生物代谢物的酶和遗传策略
  • 批准号:
    10686498
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A New Class of Chemically Modified Small RNA Inhibitors against Fusobacterium nucleatum
一类新型化学修饰小 RNA 抑制剂,抗具核梭杆菌
  • 批准号:
    10875055
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A New Class of Chemically Modified Small RNA Inhibitors against Fusobacterium nucleatum
一类新型化学修饰小 RNA 抑制剂,抗具核梭杆菌
  • 批准号:
    10353249
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Engineering Probiotics to Sense and Respond to the Intracellular Redox Imbalance towards Mitochondrial Dysfunction
工程益生菌可感知和响应细胞内氧化还原失衡导致线粒体功能障碍
  • 批准号:
    10303309
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了